Literature DB >> 10536368

Secretion of glycosylation site mutants can be rescued by the signal/pro sequence of tissue plasminogen activator.

C Köhne1, A Johnson, S Tom, D H Peers, R L Gehant, T A Hotaling, D Brousseau, T Ryll, J A Fox, S M Chamow, P W Berman.   

Abstract

Strategies that prevent the attachment of N-linked carbohydrates to nascent glycoproteins often impair intracellular transport and secretion. In the present study, we describe a method to rescue the intracellular transport and secretion of glycoproteins mutagenized to delete N-linked glycosylation sites. Site-directed mutagenesis was used to delete N-linked glycosylation sites from a chimeric protein, TNFR-IgG1. Deletion of any of the three glycosylation sites in the TNFR portion of the molecule, alone or in combination, resulted in a moderate or near total blockade of TNFR-IgG1 intracellular transport and secretion. Pulse chase experiments suggested that the glycosylation site mutants accumulated in the endoplasmic reticulum (ER) and were inefficiently exported to the Golgi apparatus (GA). Replacement of the TNFR signal sequence with the signal/pro sequence of human tissue plasminogen activator (tPA) overcame the blockade to intracellular transport, and restored secretion to levels comparable to those achieved with the fully glycosylated molecule. Ligand binding studies suggested that the secreted glycosylation variants possessed binding characteristics similar to the fully glycosylated protein. This study demonstrates that N-terminal sequences of tPA are unexpectedly efficient in facilitating transport from the ER to the GA and suggests that these sequences contain a previously unrecognized structural element that promotes intracellular transport. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10536368

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

1.  ST6Gal-I regulates macrophage apoptosis via α2-6 sialylation of the TNFR1 death receptor.

Authors:  Zhongyu Liu; Amanda F Swindall; Robert A Kesterson; Trenton R Schoeb; Daniel C Bullard; Susan L Bellis
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

2.  Circulating TNFR1 exosome-like vesicles partition with the LDL fraction of human plasma.

Authors:  Jing Zhang; Feras I Hawari; Robert D Shamburek; Barbara Adamik; Maryann Kaler; Aminul Islam; Da-Wei Liao; Farshid N Rouhani; Matthew Ingham; Stewart J Levine
Journal:  Biochem Biophys Res Commun       Date:  2007-12-17       Impact factor: 3.575

3.  Transcriptional profiles of latent human immunodeficiency virus in infected individuals: effects of Tat on the host and reservoir.

Authors:  Xin Lin; Dan Irwin; Satoshi Kanazawa; Laurence Huang; Joseph Romeo; T S Benedict Yen; B Matija Peterlin
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

4.  The role of N-glycan modification of TNFR1 in inflammatory microglia activation.

Authors:  Lijian Han; Dongmei Zhang; Tao Tao; Xiaolei Sun; Xiaojuan Liu; Guizhou Zhu; Zhiwei Xu; Liang Zhu; Yu Zhang; Wangrui Liu; Kaifu Ke; Aiguo Shen
Journal:  Glycoconj J       Date:  2015-10-09       Impact factor: 2.916

5.  A novel minigene scaffold for therapeutic cancer vaccines.

Authors:  Luigi Aurisicchio; Arthur Fridman; Ansuman Bagchi; Elisa Scarselli; Nicola La Monica; Gennaro Ciliberto
Journal:  Oncoimmunology       Date:  2014-01-16       Impact factor: 8.110

6.  The Effect of Human Recombinant Tumor Necrosis Factor Receptor-2 on Reducing Inflammatory of Collagen -Induced Arthritis in Balb/c Mice.

Authors:  Shahla Korani; Bahram Kazemi; Adel Haghighi; Amin Reza Nikpoor; Mojgan Bandehpour
Journal:  Iran J Biotechnol       Date:  2019-01-11       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.